117 results
Page 5 of 6
8-K
EX-10.1
7f5for
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
grgs5
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-99.1
pegd4kejou0hrfc
2 May 19
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
iqlv9cv60 wjrcxubyp
13 Mar 19
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.1
g85fjt rz7t
7 Nov 18
Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
np5qv
21 Sep 18
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
6n75c62x
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
c0sdkv 738p7t4tfdnh
19 Sep 18
Prospectus supplement for primary offering
4:27pm
8-K
EX-99.1
3jer n17nisel520d4f
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am